Original article published by Pharmaphorum on May 28, 2026
In this Pharmaphorum article, Jonah Comstock shares insights from PharmStars’ Pharmatech Innovation Summit. Throughout the Summit, panels comprising startups, pharma innovation leaders, and multiple stakeholders discussed how pharmaceutical companies and digital health startups can collaborate effectively to accelerate digital health adoption.
You can read the article here.
Naomi Fried, PhD
Naomi Fried, PhD, is the founder and CEO of PharmStars. She is also a founder and Managing Partner of the PharmStars Ventures Fund, which invests in the PharmStars accelerator’s graduates. Previously, she was a Partner at Ambit Health Ventures which invested in early-stage digital health device and therapeutic startups. Prior to that, Naomi was the CEO of the consulting firm Health Innovation Strategies, VP of Innovation and External Partnerships at Biogen, the first Chief Innovation Officer at Boston Children’s Hospital, and the first VP of Innovation and Advanced Technology at Kaiser Permanente. She advises and is on the boards of digital health startups.
View All Posts
